Development of adamantane scaffold containing 1,3,4-thiadiazole derivatives: Design, synthesis, anti-proliferative activity and molecular docking study targeting EGFR
- 1 May 2021
- journal article
- research article
- Published by Elsevier BV in Bioorganic Chemistry
- Vol. 110, 104794
- https://doi.org/10.1016/j.bioorg.2021.104794
Abstract
No abstract availableKeywords
Funding Information
- Al-Azhar University
This publication has 82 references indexed in Scilit:
- One-pot synthesis and anticancer studies of 2-arylamino-5-aryl-1,3,4-thiadiazolesBioorganic & Medicinal Chemistry Letters, 2011
- Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivativesEuropean Journal of Medicinal Chemistry, 2010
- Facile synthesis and cytotoxic activity of 3,6-disubstituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazolesEuropean Journal of Chemistry, 2010
- Protonation of 25,27-bis(1-octyloxy)calix[4]arene-crown-6 in the 1,3-alternate conformationMonatshefte für Chemie / Chemical Monthly, 2008
- Luminescent Biological Probes Derived from Ruthenium(II) Estradiol Polypyridine ComplexesInorganic Chemistry, 2007
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- An Adamantyl-Substituted Retinoid-Derived Molecule That Inhibits Cancer Cell Growth and Angiogenesis by Inducing Apoptosis and Binds to Small Heterodimer Partner Nuclear Receptor: Effects of Modifying Its Carboxylate Group on Apoptosis, Proliferation, and Protein-Tyrosine Phosphatase ActivityJournal of Medicinal Chemistry, 2007
- Epidermal growth factor receptor mutations in lung cancerNature Reviews Cancer, 2007
- 1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic PropertiesJournal of Medicinal Chemistry, 2003
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993